The results suggested that MTA2 can act as a prognostic biomarker in a variety of cancers and that MTA2 plays an essential role in tumor immunity by affecting tumor-infiltrating immune cells, TMB, and MSI. The gene discussed is MTA2; the disease is neoplasm.